TLDR:
- Israeli pharma company Rekah shut down its distribution system in response to a cyber attack.
- The company is working to restore the system and minimize potential damages.
The Israeli pharmaceutical company Rekah has temporarily shut down its distribution system following a cyber attack. The company, known for producing medicines, cosmetics, vitamins, and nutritional supplements, is currently investigating the incident and working to restore its compromised computer systems to operation. Rekah, a public company under the control of the Fimi fund, has identified an intrusion by an unauthorized party into the systems of its subsidiary Ophir & Shalpharm Medicines and Cosmetics, which runs the central distribution and sales system.
Upon detecting the attack, Rekah proactively shut down the affected systems and assembled a special team, including external information security experts, to handle the incident. The company is taking all possible actions to contain the attack, minimize damages, and fully restore its systems. While the extent of the damage is not believed to be substantial, Rekah is diligently working to resume distribution operations as quickly as possible.
CEO Mordechai Algrably explained that the production system at Rekah remains unaffected, and the company is considering alternative temporary supply options in case the recovery from the attack takes longer than anticipated. Algrably assured that a short shutdown of the distribution system should not cause a shortage of drugs, as customers like pharmacies and hospitals typically maintain enough stock for several days.
In conclusion, Rekah is focusing on cybersecurity measures to safeguard its operations and prevent similar incidents in the future. The company’s prompt response to the cyber attack highlights the importance of information security in the pharmaceutical industry and the need for robust protection against potential threats.